Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa

The prevalence of thrombosis in lymphoma patients is reportedly high and ranges from 3-10%. Vascular malfunction and inflammatory processes further contribute to the thrombotic activation process in these patients. Andexanet alfa (AA) is an antidote for factor Xa inhibitors and its usage has been re...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Fakiha, Antic, Darko, Tafur, Alfonso, Bontekoe, Emily, Hoppensteadt, Debra, Gerotziafas, Grigoris, Elalamy, Ismail, Fareed, Jawed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783880/
https://www.ncbi.nlm.nih.gov/pubmed/33372544
http://dx.doi.org/10.1177/1076029620983466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783880/
https://www.ncbi.nlm.nih.gov/pubmed/33372544
http://dx.doi.org/10.1177/1076029620983466

Ejemplares similares